HER2CLIMB-02: A randomized, double-blind, phase III study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer Meeting Abstract
| Authors: | Masuda, N.; Hurvitz, S.; Vahdat, L.; Harbeck, N.; Wolff, A. C.; Tolaney, S. M.; Loi, S.; O'Shaughnessy, J.; Xie, D.; Walker, L.; Rustia, E.; Borges, V. F. |
| Abstract Title: | HER2CLIMB-02: A randomized, double-blind, phase III study of tucatinib or placebo with T-DM1 for unresectable locally-advanced or metastatic HER2+ breast cancer |
| Meeting Title: | ESMO Asia Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2020 Nov 20-22 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | S1267 |
| End Page: | S1268 |
| Language: | English |
| ACCESSION: | WOS:000600988900068 |
| DOI: | 10.1016/j.annonc.2020.10.087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 67TiP -- Source: Wos |
